Financial Times
UK · 3 hrs ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
—Quality
0Ratings
0Comments
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!